Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05629611

Efficacy and Safety Evaluation of Vi-sealer

Efficacy and Safety Evaluation of Advanced Vessel Sealing Device (Vi-sealer)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
280 (estimated)
Sponsor
Hyun Park · Academic / Other
Sex
Female
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study's primary goal is to compare the efficacy and safety of the novel advanced hemostatic device(AHD), Vi-Sealer, with conventional AHDs in laparoscopic total hysterectomy for patients with benign gynecologic neoplasm.

Detailed description

Vi-Sealer is a reusable advanced bipolar electrode with an interchangeable blade. This study evaluates the efficacy and safety of the Vi-Sealer by comparing it with other advanced hemostatic devices, such as Ligasure, Enseal, Thunderbeat, Harmonic scalpel, etc. The economic evaluation of the device compared with other disposable devices would also be conducted.

Conditions

Interventions

TypeNameDescription
DEVICEVi-Sealerusing Reusable device, Vi-Sealer
DEVICELigasureusing Ligasure
DEVICEOther AHDUsing other AHDs such as Thunderbeat, Harmonic scalpel, Caiman®, Enseal, etc. except Ligasure

Timeline

Start date
2023-01-20
Primary completion
2024-12-01
Completion
2025-10-31
First posted
2022-11-29
Last updated
2024-10-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05629611. Inclusion in this directory is not an endorsement.